Breaking Barriers in Precision Oncology: One Global Companion Diagnostic Platform Across Liquid & Tissue
9:25 am - Tuesday 6th October 2026
- Guardant Health will highlight our latest global CDx regulatory approvals and advancements toward a unified platform spanning both liquid and tissue testing
- This session will showcase how Guardant Health is enabling a more streamlined, scalable, and globally consistent approach to precision oncology by delivering integrated CDx solutions across technologies, indications, and geographies
